• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Noninvasive Approaches Offer Substantial Market Potential in Liver Disease Diagnostics

Posted on: Tuesday, 19 August 2008, 06:00 CDT

Research and Markets (http://www.researchandmarkets.com/research/ff05c9/noninvasive_approa) has announced the addition of Decision Resources, Inc.'s new report "Noninvasive Approaches Offer Substantial Market Potential in Liver Disease Diagnostics" to their offering.

Novel noninvasive liver diagnostics are poised to revolutionize the diagnosis of liver disease and increase drug-treatment rates in this indication. In this report, we discuss current liver disease diagnostic techniques and summarize thought-leader perceptions of noninvasive approaches, gathered in a series of interviews with leading hepatologists. We provide a general view of the market potential for noninvasive liver diagnostics and the challenges and opportunities for companies seeking to commercialize them. To present a picture of the hypothetical market potential for noninvasive liver diagnostics in the HCV patient population, we built a simple market model based on estimations of the size of the treatment-eligible hepatitis C patient population in the United States, France, Germany, Italy, Spain, and the United Kingdom in 2008 and in 2012.

Get the Answers You Need to Shape Your Strategy:

-- Liver biopsy is widely considered the diagnostic standard for the assessment of liver - fibrosis in patients with viral hepatitis. However, the invasive procedure is not appropriate for all patients with liver disease. What are the advantages and disadvantages of this widely used procedure? What are the key unmet needs in the diagnosis and treatment of liver disease?

-- Noninvasive liver diagnostics have the potential to play a significant role in the management of patients with liver disease and dramatically expand the drug-treated population in this indication. What are the key noninvasive liver diagnostic approaches that offer an alternative to invasive liver biopsy, and what are their advantages and disadvantages? What do physicians have to say about these novel approaches? What is their market potential?

-- Algorithms that combine the use of two or more noninvasive diagnostic tests are under investigation. How do these algorithms promise to improve the ability of noninvasive diagnostic tests to determine the extent of liver disease in patients?

Scope:

-- Liver disease: overview of liver disease.

-- Liver function diagnostics: discussion of the liver biopsy procedure; coverage of key noninvasive diagnostics.

-- Diagnostics algorithms: coverage of key liver diagnostics algorithms.

-- Thought-leader insight: in-depth discussion of physicians' perceptions of the use of noninvasive diagnostics in liver disease.

-- Market potential of noninvasive liver diagnostics: market model provides a picture of the hypothetical market potential of these approaches in the hepatitis C virus population in the United States, France, Germany, Italy, Spain, and the United Kingdom in 2008 and 2012.

Mentioned in This Spectrum Report: -- Noninvasive Tests: - FibroScan - FIBROSpect II - FibroTest - FibroTest-ActiTest - HCV-FibroSure -- Indications: - Alcoholic liver disease - Cirrhosis - End-stage liver disease - Fibrosis - Hepatitis B - Hepatitis C - Hepatocellular carcinoma - HIV - Nonalcoholic fatty liver disease

Key Topics Covered: Executive Summary Strategic Considerations Stakeholder Implications Overview What Is Liver Disease? Liver Function Diagnostics Liver Biopsy: A Standard Impact of Liver Biopsy on Treatment Rates Cost and Reimbursement of Liver Biopsy in the United States Noninvasive Liver Diagnostics Aspartate Aminotransferase to Platelet Ratio Index Forns' Index FIBROSpect II FibroTest-ActiTest and HCV-FibroSure FibroScan Novel Diagnostics Algorithms APRI-FIBROSpect II FibroTest-FibroScan APRI-FibroTest Thought-Leader Opinion Market Potential of Noninvasive Liver Diagnostics Appendix A Bibliography Sidebar Utility of the Liver Biopsy: Notes on Scoring List of Tables 1 Advantages and Disadvantages of Liver Biopsy and Noninvasive Liver Diagnostics 2 Select Noninvasive Diagnostics in Liver Disease 3 Key Issues in Liver Diagnostics: Thought-Leader Consensus List of Figures 1 Diagnostic Algorithm for FibroTest-FibroScan 2 Diagnostic Algorithm for Significant Fibrosis in Chronic HCV and HBV Patients 3 Diagnostic Algorithm for Cirrhosis in Chronic HCV and HBV Patients 4 Hypothetical Market Potential for Noninvasive Liver Diagnostics, 2008 and 2012: Scenario 1 5 Hypothetical Market Potential for Noninvasive Liver Diagnostics, 2008 and 2012: Scenario 2

Companies Mentioned:

-- BioPredictive

-- EchoSens

-- LabCorp

-- Prometheus Laboratories

For more information visit http://www.researchandmarkets.com/research/ff05c9/noninvasive_approa

Source: Business Wire

More News in this Category